Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia
P. Milne, C. Wilhelm-Benartzi, M. R. Grunwald, V. Bigley, A. Publicover, S. Pagan, H. Marr, G. Jones, A. Dickinson, A. Grech, A. Burnett, N. Russell, M. Levis, S. Knapper, M. Collin
This paper shows that serum Flt3L levels correlate with progenitor cell mass and prognosis in AML, with lower levels linked to worse outcomes and relapse.
bioRxiv · Mar 25, 2019Cancer Biology